DUBLIN, November 5, 2013 /PRNewswire/ --
Research and Markets ( http://www.researchandmarkets.com/research/66tsj8/analysis_of) has announced the addition of the "Analysis of Global Biochips Industry, 2012-2018" report to their offering.
Global biochips market is forecasted to reach US$11.4 billion by 2018 with a CAGR of 18.6% during 2012-2018; the massive CAGR is primarily supported by Asia-Pacific followed by the European Union. Among the major industry segments, biochips instruments are expected to exert the highest support to the industry with a CAGR of 20% globally.
The evolution of biochips has opened new vistas in the biological systems. In addition, all other sciences are integrated which cumulatively contribute for a big future of biochip industry. The broad life science' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. Accelerating growth rate exhibited by the biochips industry, even during the recession years, confirms the positive growth prospects going ahead. The field of drug discovery and development research gets more glamorous with the diagnostics and treatment at cellular level. DNA biochips and lab-on-chips have created revolution enabling the target validation. Genome scan is very soon going to become an ultimate weapon for diagnosis. In no time all the information related to genes will be sequenced, annotated and completed along with the list of diseases which are susceptible. Day to day the researchers are also making an effort to develop medication to control the various diseases, by using biochip technology. As the applications of biochips
|SOURCE Research and Markets|
Copyright©2012 PR Newswire.
All rights reserved